Low-resolution electromagnetic tomography and treatment response in obsessive-compulsive disorder.
暂无分享,去创建一个
Pedro Ribeiro | Leonardo Franklin Fontenelle | R. Piedade | P. Ribeiro | M. Mendlowicz | M. Versiani | Leonardo F Fontenelle | Mauro V Mendlowicz | Marcio Versiani | Roberto A Piedade
[1] H. Leonard,et al. Obsessive-compulsive disorder. , 2003, Child and adolescent psychiatric clinics of North America.
[2] F. Vollenweider,et al. Comparison of simultaneously recorded [H215O]‐PET and LORETA during cognitive and pharmacological activation , 2004, Human brain mapping.
[3] Pedro Ribeiro,et al. Neurocortical electrical activity tomography in chronic schizophrenics. , 2003, Arquivos de neuro-psiquiatria.
[4] Dennis Velakoulis,et al. Anterior cingulate dysfunction: implications for psychiatric disorders? , 2003, Journal of psychiatry & neuroscience : JPN.
[5] Cameron S. Carter,et al. Overactive Action Monitoring in Obsessive-Compulsive Disorder , 2003, Psychological science.
[6] Matthew L. Ho,et al. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. , 2003, The American journal of psychiatry.
[7] F. Karadağ,et al. QUANTITATIVE EEG ANALYSIS IN OBSESSIVE COMPULSIVE DISORDER , 2003, The International journal of neuroscience.
[8] N. Alpert,et al. Predictors of Fluvoxamine Response in Contamination-related Obsessive Compulsive Disorder: A PET Symptom Provocation Study , 2002, Neuropsychopharmacology.
[9] A. Özge,et al. Association of QEEG Findings with Clinical Characteristics of OCD: Evidence of Left Frontotemporal Dysfunction , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[10] Leonardo Franklin Fontenelle,et al. The effect of gender on the clinical features and therapeutic response in obsessive-compulsive disorder , 2002 .
[11] D. Lehmann,et al. Functional imaging with low-resolution brain electromagnetic tomography (LORETA): a review. , 2002, Methods and findings in experimental and clinical pharmacology.
[12] R. Davidson,et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. , 2001, The American journal of psychiatry.
[13] S. Alborzian,et al. Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder , 1999, Neuropsychopharmacology.
[14] J. Lorberbaum,et al. Mirtazapine treatment of obsessive-compulsive disorder , 1999, European Neuropsychopharmacology.
[15] P. Fox,et al. Cingulate function in depression: a potential predictor of treatment response , 1997, Neuroreport.
[16] M. First,et al. Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet , 1997 .
[17] Karl J. Friston,et al. Detecting Activations in PET and fMRI: Levels of Inference and Power , 1996, NeuroImage.
[18] J. R. Baker,et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. , 1996, Archives of general psychiatry.
[19] D. Zabel,et al. Diagnostic and Statistical Manual of Mental Disorders, 4th ed , 1995 .
[20] Suck-Won Kim,et al. The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency , 1994, Psychiatry Research.
[21] P Pietrini,et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. , 1992, Archives of general psychiatry.
[22] W. Goodman,et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.
[23] J. Rapoport,et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. , 1989, Archives of general psychiatry.
[24] M. Hamilton,et al. Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.